Caleco Pharma Corp. engages since January 2009 in the acquisition and development of over-the-counter medication and FDA approved pharmaceuticals. According to a technology purchase agreement with NY Financial (International) Corp, the company owns the proprietary technology 'Liver Health Formula" and intellectual property, related to the treatment of liver disease and other ailments that results from viral infections such as the Hepatitis C virus infection. Derived from that technology, the company also has developed or is in the process of developing food supplements, hair and dermatological products, energy drinks and chewing gum. Patent applications...
Currently promoted by three different promoters, the stock of Caleco Pharma Corp. (OTC:CAEH) dropped severely yesterday. The lack of fundamentals and the still missing significant improvements of the biotechnology company made investors sell out intensively.read more
CALECO PHARMA CORP. (CAEH) MESSAGE BOARD
Post #
Subject
Re
Name
Date
There are no comments.
Would you like to be notified if someone replies to your post?
someone replies to your post?